DBD logo

DBD

Profile

Full Name

Diebold Nixdorf, Incorporated

Ticker Symbol

DBD

Exchange

NYSE

Sector

Technology

Industry

Software Application

Country

United States

IPO

August 14, 2023

Indexes

Not included

Website

http://www.dieboldnixdorf.com

Employees

21000

Key Details

Price

$42.50(+1.07%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$3.75B

Annual EPS

-$0.44

PE ratio

-

Next earnings date

May 2, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$42.50
DBD price is $42.50

30-Day Relative Volume

1.17
DBD 30-day relative volume is 1.17

Price Performance

Price Today change

+1.07%
DBD price is up +1.07% today

Price YTD change

-1.25%
DBD price is down -1.25% since January 1st

Price 1-year change

+29.18%
DBD price is up +29.18% year-on-year

Price 3-year change

-
DBD price 3-year change is unknown

Price Range

Price All-time high

$51.81
DBD price is currently -17.97% below its historical high of $51.81

Price 3-year low

$16.50
DBD price is currently +157.58% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$1.60B
DBD market capitalization is $1.60 billion

Market cap 3-year change

-
DBD market capitalization 3-year change is unknown

Market cap All-time high

$1.87B
DBD market capitalization is currently -14.69% below its historical high of $1.87 billion

Market cap sector rank

62.41%
DBD market capitalization is higher than 62.41% of companies in Technology sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.17%
DBD shares outstanding is up +0.17% year-on-year

Shares Outstanding 3-Year Change

-52.33%
DBD shares outstanding is down -52.33% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.11
DBD beta is 1.11

200-day SMA

$43.18
DBD price is currently -1.57% below its 200-day simple moving average

50-day SMA

$43.17
DBD price is currently -1.54% below its 50-day simple moving average

RSI

50.00
DBD 14-day relative strength index is 50.00

Volume

1.17
DBD 30-day relative volume is 1.17

ATR

$2.18
DBD average true range is $2.18

10-day Historical Volatility

91.33%
DBD 10-day historical volatility is 91.33%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$3.75B
DBD annual revenue is $3.75 billion

Revenue Analysts estimate

$3.78B
DBD annual revenue is currently -0.68% lower than the consensus analysts' forecast

Revenue 1-year change

-
DBD annual revenue 1-year change is unknown

Revenue Sector rank

84.2%
DBD annual revenue is higher than 84.2% of companies in Technology sector

EPS

EPS

-$0.44
DBD annual earnings per share is -$0.44

EPS Analysts estimate

$3.85
DBD annual earnings per share is currently -111.44% lower than the consensus analysts' forecast

EPS 1-year change

-
DBD annual earnings per share 1-year change is unknown

EPS Sector rank

38.01%
DBD annual earnings per share is higher than 38.01% of companies in Technology sector

Profit

Gross profit

$920.00M
DBD annual gross profit is $920.00 million

Gross margin

24.53%
DBD annual gross profit margin is 24.53%

Operating profit

$182.80M
DBD annual operating income is $182.80 million

Operating margin

4.87%
DBD annual operating profit margin is 4.87%

Net income

-$16.50M
DBD annual net profit is -$16.50 million

Net margin

-0.44%
DBD annual net profit margin is -0.44%

Expenses

Total expenses

$3.57B
DBD annual total expenses is $3.57 billion

Operating expenses

$737.20M
DBD annual total operating expenses is $737.20 million

Cost of goods sold

$2.83B
DBD annual cost of goods sold is $2.83 billion

Selling, general & administrative expenses

$643.60M
DBD annual SGA is $643.60 million

Depreciation and amortization

$132.30M
DBD annual depreciation & amortization is $132.30 million

Interest expense

$155.30M
DBD annual interest expense is $155.30 million

Income tax

$64.30M
DBD annual income tax is $64.30 million

EBIT & EBITDA

EBIT

$202.60M
DBD annual earnings before interest & taxes is $202.60 million

EBITDA

$334.90M
DBD annual EBITDA is $334.90 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$3.54B
DBD annual total assets is $3.54 billion

Non current assets

$1.88B
DBD annual long term assets is $1.88 billion

Current assets

$1.67B
DBD annual total current assets is $1.67 billion

Cash and cash equivalents

$311.30M
DBD annual cash & cash equivalents is $311.30 million

Accounts receivable

$588.50M
DBD annual accounts receivable is $588.50 million

Inventory

$528.10M
DBD annual inventory is $528.10 million

Liabilities

Total liabilities

$2.61B
DBD annual total liabilities is $2.61 billion

Long term liabilities

$1.34B
DBD annual total long term liabilities is $1.34 billion

Current liabilities

$1.27B
DBD annual total current liabilities is $1.27 billion

Accounts payable

$460.20M
DBD annual accounts payable is $460.20 million

Debt

Total debt

$1.05B
DBD annual total debt is $1.05 billion

Total debt 1-year change

-22.86%
DBD annual total debt is down -22.86% year-on-year

Long term debt

$1.00B
DBD annual long term debt is $1.00 billion

Short term debt

$43.50M
DBD annual short term debt is $43.50 million

Equity & Capital

Shareholders equity

$929.80M
DBD annual stockholders equity is $929.80 million

Book value

$929.80M
DBD annual book value is $929.80 million

Retained earnings

-$1.10M
DBD annual retained earnings is -$1.10 million

Working capital

$401.60M
DBD annual working capital is $401.60 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$149.20M
DBD annual cash flow from operations is $149.20 million

Cash from operations 1-year change

-
DBD annual cash flow from operations 1-year change is unknown

Cash from investing

-$45.50M
DBD annual cash flow from investing activities is -$45.50 million

Cash from investing 1-year change

-
DBD annual cash flow from investing activities 1-year change is unknown

Cash from financing

-$366.50M
DBD annual cash flow from financing activities is -$366.50 million

Cash from financing 1-year change

-
DBD annual cash flow from financing activities 1-year change is unknown

CAPEX

CAPEX

$40.40M
DBD annual capital expenditures is $40.40 million

CAPEX 1-year change

-
DBD annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

$108.80M
DBD annual free cash flow is $108.80 million

Free cash flow 1-year change

-
DBD annual free cash flow 1-year change is unknown

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

24.53%
DBD annual gross profit margin is 24.53%

Operating margin

4.87%
DBD annual operating profit margin is 4.87%

Net margin

-0.44%
DBD annual net profit margin is -0.44%

ROA & ROE

ROA

-0.50%
DBD annual return on assets is -0.50%

ROE

-1.64%
DBD annual return on equity is -1.64%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
DBD price to earnings ratio value is unknown

PE ratio Sector rank

-
DBD price to earnings ratio is unknown

PB Ratio

PB ratio

1.72
DBD price to book ratio is 1.72

PB ratio Sector rank

46.07%
DBD price to book ratio is higher than 46.07% of companies in Technology sector

PS Ratio

PS ratio

0.43
DBD price to sales ratio is 0.43

PS ratio Sector rank

13.96%
DBD price to sales ratio is higher than 13.96% of companies in Technology sector

Enterprise value

Enterprise value

$2.35B
DBD enterprise value is $2.35 billion

Enterprise value Sector rank

64.25%
DBD enterprise value is higher than 64.25% of companies in Technology sector

EV/EBITDA

EV/EBITDA

7.02
DBD EV/EBITDA is 7.02

EV/EBITDA Sector rank

50.21%
DBD EV/EBITDA is higher than 50.21% of companies in Technology sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.32
DBD annual current ratio is 1.32

Quick ratio

0.90
DBD annual quick ratio is 0.90

Leverage

Debt to equity

1.00
DBD annual debt to equity ratio is 1.00

Interest coverage ratio

1.30
DBD annual interest coverage ratio is 1.30

Risk & Stability

Piotroski F-Score

-
DBD piotroski f-score value is unknown

Altman Z-Score

1.75
DBD altman z-score is 1.75

Analyst ratings

Recent major analysts updates

Feb 27, 25 DA Davidson
Buy
Aug 9, 24 DA Davidson
Buy
Aug 8, 24 Wedbush
Outperform
Jul 25, 24 Wedbush
Outperform
May 3, 24 Wedbush
Outperform
Apr 25, 24 Wedbush
Neutral
Feb 15, 24 Wedbush
Neutral
Feb 12, 24 Wedbush
Neutral
Nov 10, 23 Wedbush
Neutral
Nov 10, 23 DA Davidson
Buy

Institutional Ownership

Similar stocks

AVDX logo
AvidXchange Holdings (AVDX)
DIOD logo
Diodes Incorporated (DIOD)
CNXN logo
PC Connection (CNXN)
NN logo
NextNav (NN)
KLIC logo
Kulicke and Soffa Industries (KLIC)
PLUS logo
ePlus (PLUS)
EXTR logo
Extreme Networks (EXTR)
RAMP logo
LiveRamp Holdings (RAMP)
Pony AI American Depositary Shares (PONY)
  • What is the ticker symbol for Diebold Nixdorf Incorporated?
  • Does Diebold Nixdorf Incorporated pay dividends?
  • What sector is Diebold Nixdorf Incorporated in?
  • What industry is Diebold Nixdorf Incorporated in?
  • What country is Diebold Nixdorf Incorporated based in?
  • When did Diebold Nixdorf Incorporated go public?
  • Is Diebold Nixdorf Incorporated in the S&P 500?
  • Is Diebold Nixdorf Incorporated in the NASDAQ 100?
  • Is Diebold Nixdorf Incorporated in the Dow Jones?
  • When was Diebold Nixdorf Incorporated's last earnings report?
  • When does Diebold Nixdorf Incorporated report earnings?
  • Should I buy Diebold Nixdorf Incorporated stock now?

What is the ticker symbol for Diebold Nixdorf Incorporated?

The ticker symbol for Diebold Nixdorf Incorporated is NYSE:DBD

Does Diebold Nixdorf Incorporated pay dividends?

No, Diebold Nixdorf Incorporated does not pay dividends

What sector is Diebold Nixdorf Incorporated in?

Diebold Nixdorf Incorporated is in the Technology sector

What industry is Diebold Nixdorf Incorporated in?

Diebold Nixdorf Incorporated is in the Software Application industry

What country is Diebold Nixdorf Incorporated based in?

Diebold Nixdorf Incorporated is headquartered in United States

When did Diebold Nixdorf Incorporated go public?

Diebold Nixdorf Incorporated's initial public offering (IPO) was on August 14, 2023

Is Diebold Nixdorf Incorporated in the S&P 500?

No, Diebold Nixdorf Incorporated is not included in the S&P 500 index

Is Diebold Nixdorf Incorporated in the NASDAQ 100?

No, Diebold Nixdorf Incorporated is not included in the NASDAQ 100 index

Is Diebold Nixdorf Incorporated in the Dow Jones?

No, Diebold Nixdorf Incorporated is not included in the Dow Jones index

When was Diebold Nixdorf Incorporated's last earnings report?

Diebold Nixdorf Incorporated's most recent earnings report was on Feb 12, 2025

When does Diebold Nixdorf Incorporated report earnings?

The next expected earnings date for Diebold Nixdorf Incorporated is May 2, 2025

Should I buy Diebold Nixdorf Incorporated stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page